Lifecore Biomedical, Inc. (LFCR)
7.46
-0.13
(-1.71%)
USD |
NASDAQ |
Jan 13, 16:00
7.48
+0.02
(+0.27%)
After-Hours: 20:00
Lifecore Biomedical Research and Development Expense (Quarterly): 1.963M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cytokinetics, Inc. | 96.55M |
| Integer Holdings Corp. | 10.95M |
| Inspire Medical Systems, Inc. | 24.21M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |